Spiritual and mind-body beliefs as barriers and motivators to HIV-treatment decision-making and medication adherence? A qualitative study

AIDS Patient Care and STDs

Volumn 23, Issue 2, 2009, Pages 127-134

  Kremer, Heidemarie ^a   Ironson, Gail ^a   Porr, Martina ^a  

^a Department of Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; FEMALE; HEALTH; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUESTIONNAIRE; RELIGION; SURVIVAL; SYMPTOM;

ADULT; ANTI-HIV AGENTS; DECISION MAKING; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIND-BODY RELATIONS (METAPHYSICS); PATIENT COMPLIANCE; QUESTIONNAIRES; RELIGION; SPIRITUALITY; TREATMENT REFUSAL;

EID: 60749108717     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0131     Document Type: Article

References (40)

1. Cole SR, Hernan MA, Robins JM, et al. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol 2003;158:687-694.
2. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
3. May M, Sterne JA, Sabin C, et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: Collaborative analysis of prospective studies. AIDS 2007;21:1185-1197.
4. Strategies for Management of Antiretroviral Therapy (SMART) Study Group, Lundgren JD, Babiker A, El-Sadr W, et al. Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4+ cell counts and HIV RNA levels during follow-up. J Infect Dis 2008;197:1145-1155.
5. Tebas P, Henry WK, Matining R, et al. Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: Implications for cardiovascular risk. PLoS ONE 2008;23;3:e2021.
6. Bangsberg DR, Moss AR, Deeks SG. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother 2004;53:696-699.
7. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy? AIDS 2003;17:711-720.
8. D'Ambrosio M. Loose yourself to find yourself. www.crossroadsinitiative. com/library-article/133/Lose-Yourself-to-Find-Yourself.html (Last accessed July 17, 2008).
9. Ironson G, Kremer H, Ironson D. Spirituality, spiritual experiences, and spiritual transformations in the face of HIV. In: Koss JD, Hefner P, eds. Spiritual Transformation and Healing: Anthropological, Theological, Neuroscientific, and Clinical Perspectives, 1st ed. Lanham, MD: AltaMira Press, 2006:241-262.
10. Pargament K. The meaning of spiritual transformation. In: Koss JD, Hefner P, eds. Spiritual Transformation and Healing: Anthropological, Theological, Neuroscientific, and Clinical Perspectives, 1st ed. Lanham, MD: AltaMira Press, 2006:10-24.
11. Kim J. Problems in the Philosophy of Mind. Oxford Companion to Philosophy. In: Honderich T, ed. Oxford: Oxford University Press, 1995, pp. 3-8.
12. Gallup G, Lindsay DM. Surveying the Religious Landscape: Trends in the U.S. Beliefs. Harrisburg, PA: Morehouse, 1999.
13. Ehman JW, Ott BB, Short TH, Ciampa RC, Hansen-Flaschen J. Do patients want physicians to inquire about their spiritual or religious beliefs if they become gravely ill? Arch Intern Med 1999;159:1803-1806.
14. Kremer H, Ironson G. Spirituality and HIV. In: Plante TG, Thoresen CE, eds. Spirit, Science, and Health: How the Spiritual Mind Fuels Physical Wellness, 1st ed. Westport, CT: Greenwood Publishing Group, 2007, pp. 176-191.
15. Pargament KI, McCarthy S, Shah P, Ano G, Tarakeshwar N, Wachholtz A, et al. Religion and HIV: A review of the literature and clinical implications. South Med J 2004;97:1201-1209.
16. Kremer H, Ironson G, Schneiderman N, Hautzinger M. To take or not to take: Decision-making about antiretroviral treatment in people living with HIV/AIDS. AIDS Patient Care STDs 2006;20:335-349.
17. Holstad MK, Pace JC, De AK, Ura DR. Factors associated with adherence to antiretroviral therapy. J Assoc Nurses AIDS Care 2006;17:4-15.
18. Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav 2006;10:227-245.
19. Parsons SK, Cruise PL, Davenport WM, Jones V. Religious beliefs, practices and treatment adherence among individuals with HIV in the southern United States. AIDS Patient Care STDs 2006;20:97-111.
20. Kremer H, Bader A, O'Cleirigh C, Bierhoff HW, Brockmeyer NH. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership? Eur J Med Res 2004;9:61-70.
21. Kremer H. Compliance in der HIV-Therapie unter dem Aspekt der Selbstbestimmung. [Compliance with HIV-therapy under the aspect of patient's autonomy] Master's thesis. Bochum, Germany: Department of Psychology, Ruhr University Bochum; 2001.
22. Ironson G, Stuetzle R, Fletcher MA. An increase in religiousness/ spirituality occurs after HIV diagnosis and predicts slower disease progression over 4 Years in people with HIV. J Gen Intern Med 2006;21(Suppl 5):S62-68.
23. Aversa SL, Kimberlin C. Psychosocial aspects of antiretroviral medication use among HIV patients. Patient Educ Couns 1996;29:207-219.
24. Kremer H, Ironson G. To tell or not to tell: Why people with HIV share or don't share with their physicians whether they are taking their medications as prescribed. AIDS Care 2006;18:520-528.
25. Ironson G, Balbin E, Stuetzle R, et al. Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: Proactive behavior, avoidant coping, and depression. Int J Behav Med 2005;12:86-97.
26. Department of Health and Human Services (DHHS) (US). Guidelines for the use of antiretroviral Agents in HIV-Infected Adults and Adolescents. January 29, 2008. www.aidsinfo.nih.gov/Guidelines/ (Last accessed July 17, 2008).
27. Kremer H. Medical decision-making, adherence and quality of life in people living with HIV/AIDS. University of Tuebingen, Germany; 2005.
28. AIDS Clinical Trials Group (ACTG). ACTG Adherence follow-up questionnaire. 2001.
29. Mayring P. Qualitative content analysis. Forum: qualitative social research 2000. January 2003. www.qualitativeresearch.net/fqs-texte/1-03/1- 03hooperetal-e.htm (Last accessed July 17, 2008).
30. Mayring P. Qualitative Inhaltsanalyse. Grundlagen und Techniken. [Qualitative content analysis. Basics and techniques]. 7th ed. Weinheim, Germany: Deutscher Studien Verlag, 2000.
31. Spannagel C, Gläser-Zikuda M, Schroeder U. Application of Qualitative Content Analysis in User-Program Interaction Research. Available at: Forum: Qualitative Social Research 2005;6(2). http://217.160.35.246/fqs-texte/ 2-05/05-2-29-e.htm (Last accessed July 17, 2008).
32. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
33. Bandura A. Social cognitive theory: An agentic perspective. Annu Rev Psychol 2001;52:1-26.
34. Kuczewski MG. Talking about spirituality in the clinical setting: Can being professional require being personal? Am J Bioeth 2007;7:4-11.
35. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000;12:255-266.
36. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. J Acquir Immune Defic Syndr 2002;31(Suppl 3):S123-127.
37. Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006;3:e438.
38. Fehr JS, Nicca D, Sendi P, et al. Starting or changing therapy - A prospective study exploring antiretroviral decision-making. Infection 2005;33:249-256.
39. Kremer H. Adherence to Antiretroviral Therapy (ART) in People Living with HIV: Supporting the Art of ART. 2007. www.healthforumonline.com/Our-Courses/ Courses/47/productId-61/ (Last accessed July 17, 2008).
40. Rier DA, Indyk D. Flexible rigidity: Supporting HIV treatment adherence in a rapidly-changing treatment environment. Soc Work Health Care 2006;42:133-150.